Due to the pandemic, the District Court entered an Order today cancelling all criminal and civil jury trials in the United States District Court for the District of Delaware until
Continue Reading Court Enters Order Cancelling Civil and Criminal Jury Trials in the District of Delaware Until On or After April 5, 2021 Due to COVID-19 Pandemic

By Memorandum Opinion entered in Allergan USA, Inc. et al. v. Aurobindo Pharma Ltd., et al., Civil Action No. 19-1727-RGA (D.Del. January 11, 2021), The Honorable Richard G. Andrews construed
Continue Reading Judge Andrews Issues Markman Opinion Construing Five Remaining Terms in Dispute in Six Patents-in-Suit in Hatch-Waxman Action

By Standing Order entered by Chief District Judge Leonard P. Stark on September 1, 2020, the United States District Court for the District of Delaware announced its plan to transition
Continue Reading District of Delaware Announces Plan to Transition to Phase 2 of the District’s Re-Opening Guidelines on September 15, 2020

By Memorandum Order entered by The Honorable Leonard P. Stark in Xcoal Energy & Resources v. Bluestone Energy Sales Corp., Civil Action No. 18-819-LPS (D.Del. August 18, 2020), the
Continue Reading Chief Judge Stark Denies Defendants’ Request to Convert Remote Bench Trial Ordered in Light of COVID-19 Pandemic to In-Person Trial

By Opinion entered by The Honorable Leonard P. Stark in Bristol-Myers Squibb Co. et al v. Aurobindo Pharma USA Inc. et al., Civil Action No. 17-374-LPS (D.Del. August 5,
Continue Reading Following ANDA Trial, Chief Judge Stark Finds Remaining Defendants’ Proposed Drug Products Infringe Asserted Claims of Patents-in-Suit Connected to Plaintiffs’ Eliquis® Product